Carmell Therapeutics (CTCX) via Alpha Healthcare Acq III (ALPA) deck
Carmell Therapeutics is a Phase 2 stage biotechnology platform company developing allogeneic plasma-based biomaterials that are designed to boost innate regenerative pathways across a variety of bone and soft tissue indications.
This post is for subscribers onlySubscribe
Already have an account? Log in